respiratory pharmacology: pulmonary vascular diseases€¦ · department of anesthesiology,...

26
Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart Lung Innovation, St Paul’s Hospital [email protected] Respiratory Pharmacology: Pulmonary vascular diseases

Upload: others

Post on 07-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Dr. Tillie-Louise HackettDepartment of Anesthesiology, Pharmacology and Therapeutics

University of British Columbia

Associate Head, Centre of Heart Lung Innovation, St Paul’s [email protected]

Respiratory Pharmacology: Pulmonary vascular diseases

Page 2: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Aims of LectureDefine: Features of Pulmonary vasculature

Blood-Gas barrierCell structure functionPulmonary edemaMetabolism potential of the human lung

Page 3: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pulmonary Vasculature

Weibel, 2009, Swiss Med Wkly

GAS EXCHANGE STRUCTURE

~ 300 alveoli units in a human lung

Page 4: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pulmonary verses systemic circulation

Pressure difference: Pul: 15-5 = 10 Sys: 100-2 = 98 (10x that of pulmonary pressure)

Low PressureLow Resistance

Page 5: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pressure of pulmonary capillaries

Pulmonary system can have extremely thin walls

Page 6: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Compression of capillaries with increased alveolar pressures

Page 7: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Small pulmonary vein

Page 8: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Effect of lung volume on resistance

Page 9: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Alveolar gas is very close to the wall of the artery

Smooth Muscle surroundingarteries maintains pressure

Less effect of radial traction

But is sensitive to nitric oxide produced by the oxidationstatus of the alveoli

Page 10: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Low alveolar PO2 causes vasoconstriction

Chronic bronchitus

Vasocontriction shuts of valves

Page 11: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Blood- Gas Barrier

Page 12: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pulmonary capillary has a very thin wall

Page 13: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pulmonary Blood-Gas Barrier & FunctionEPI: Epithelial Type I cellIN: InterstitiumEN: Endothelial Cell

Look similar but theirfunctions are Completely different!

Endothelium highly permeable to water, solutes, ions and some proteins (albumin)Alveolar impermeable!

Page 14: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Intracellular Junctions

Endothelium

Weak adhesions

Buffered together

Epithelium

Tight Junctions

Velcro

Page 15: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pulmonary Edema

15Weibel, 2009, Swiss Med Wkly

Definition: An abnormal accumulation of fluid in the extravascular spaces and tissues of the lung

= means fluid should be within the capillariesAnd fluid has leaked out

Accompanies many lung and heart diseases and is often lethal

Page 16: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Electron Micrograph of Pulmonary capillary

Pulmonary Edema: Fluid leaks into interstitium or alveolar space

Page 17: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Two stages of Pulmonary Edema

Lymph

Lymph

LymphA. Normal

B. Interstitial Edema

B. Alveolar Edema

Peri vascularspace

Epithelial DamageResults in RBCs inAlveolar lining fluid

Page 18: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Interstitium of the lung

Perivascular andPeribronchiole spaces

Lymph nodes

Page 19: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Small pulmonary vein

Page 20: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Peri vascular cuff

Page 22: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Effect of Pulmonary edema Interstitial edema Generally little effect on lung function Some evidence that lung compliance is reduced

Alveolar Edema Lung compliance is reduced Airway compliance is reduced Seriously reduced O2 – CO2 transfer

Page 23: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Pathogenesis of Pulmonary Edema

1) Increased Capillary Hydrostatic Pressure

Caused by Myocardial Infarction Heart attack, left atrium fails, increase in pressure

2) Increased Capillary Permeability

Caused by capillary wall abnormalities Inhaled or circulating toxins (chlorine gas) Radiation (Breast cancer treatment)

Page 24: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Treatment for Pulmonary Edema

Oxygen Therapy: Most influential

Preload reducers: Use nitroglycerin and diuretics, such as furosemide (Lasix), to decrease the pressure caused by fluid going into your heart and lungs.

Afterload reducers: These drugs dilate your blood vessels and take a pressure load off your heart's left ventricle e.g. Nitropress, Vasotec.

Page 25: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Substances metabolized by the lung

Biological activation: Angiotensin I is converted to the vasoconstrictor, angiotensin II via ACE

ACE inhibitors (Ramipril) – Decrease tension on vessels, decreasing blood flow

Biological inactivation:. Examples include bradykinin, serotonin, prostaglandins E1, E2, and F2 alpha. Norepinephrine is also partially inactivated

Enterochromaffin cells in gut, secrete serotonin and in blood the platelets store it and release it when they bind clots – acts as vasconstrictor

Not affected: Examples include epinephrine, angiotensin II and vasopressin.

Metabolized and released: Examples include the arachidonic acid metabolites - the leukotrienes, and prostaglandins.

Page 26: Respiratory Pharmacology: Pulmonary vascular diseases€¦ · Department of Anesthesiology, Pharmacology and Therapeutics . University of British Columbia. Associate Head, Centre

Questions